Approval · Notice of Compliance 2533 · 2001
HYATE:C: Notice of Compliance 2533
Issued February 1, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2533
- Date
- February 1, 2001
- Company
- Ipsen Biopharm LimitedWrexham, Wales, United Kingdom
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antihemophilic factor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYATE:C | 02156075 | Cancelled Post Market |
Medicinal ingredients
- PORCINE FACTOR VIII-C 700 UNIT per VIAL